JPRN-UMIN000004240已完成未知
A feasibility study of Docetaxel/Bevacizumab in elderly patients with advanced non-small cell lung cancer (TORG1014) - TORG1014
Thoracic Oncology Research Group(TORG)0 个研究点目标入组 12 人开始时间: 2010年9月24日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 70years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Patients with brain metastasis. 2. Patients with current or previous hemoptysis. 3. Patients treated with radiation therapy for thoracic region. 4. Patients with active severe infections. 5. Patients who have fever of over 38 degrees. 6. Patients with serious complication (cardiac affection, interstitial pneumonia, uncontrollable hypertension, or uncontrollable diabetes mellitus, etc.) 7. Patients with massive ascites, pleural or pericardial effusion. 8. Patients with concomitant malignancy. 9. Patients with history of drug allergies. 10. Patients with uncontrollable gastrointestinal ulceration. 11. Patients with current or previous (within one year) history of gastrointestinal perforation. 12. Patients treated with anticoagulation therapy 13. Inappropriate patients for this study judged by the physicians
研究者
相似试验
已完成
不适用
Feasibility study of Docetaxel plus Bevacizumab in selected patient with previously treated advanced NSCLS(non-squamous).Previously treated advanced NSCLC(non-squamous)JPRN-UMIN000003397Cancer Institute Hospital Japanese Foundation for Cancer Research15
招募中
2 期
A Phase 2 study of Docetaxel and Bevacizumab as the second line treatment for patients with non-squamous non-small cell lung cancer previously treated with platinum-based chemotherapy.non-squamous non-small cell lung cancerJPRN-UMIN000006641Kinki University Faculty of Medicine, Nara Hospital41
已完成
1 期
Phase I/II study of Docetaxel with Bevacizumab for refractory and geriatric non-squamous non-small cell lung canceron-Squamous Non-Small Cell Lung CancerJPRN-UMIN000006152Chiba Tokushukai Hospital20
已完成
2 期
Phase II Study of Docetaxel+Bevacizumab with non-squamous non-small cell lung cancer for patients pretreated with chemotherapyon-small-cell lung cancerJPRN-UMIN000005077Tochigi Cancer Center22
已完成
2 期
A phase II study of Docetaxel with Bevacizumab for EGFR mutation negative previously treated non-squamous non-small cell lung canceron-Squamous Non-Small Cell Lung CancerJPRN-UMIN000006532ihon University School of Medicine30